Literature DB >> 21282719

Pathophysiology of thrombosis in myeloproliferative neoplasms.

Raffaele Landolfi, Leonardo Di Gennaro.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21282719      PMCID： PMC3031683          DOI： 10.3324/haematol.2010.038299

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  22 in total

1.  Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera.

Authors:  A Falanga; M Marchetti; V Evangelista; A Vignoli; M Licini; M Balicco; S Manarini; G Finazzi; C Cerletti; T Barbui
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

2.  Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo.

Authors:  R Landolfi; G Ciabattoni; P Patrignani; M A Castellana; E Pogliani; B Bizzi; C Patrono
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

3.  Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3.

Authors:  Tiziano Barbui; Alessandra Carobbio; Guido Finazzi; Alessandro M Vannucchi; Giovanni Barosi; Elisabetta Antonioli; Paola Guglielmelli; Alessandro Pancrazzi; Silvia Salmoiraghi; Pio Zilio; Cosimo Ottomano; Roberto Marchioli; Ivan Cuccovillo; Barbara Bottazzi; Alberto Mantovani; Alessandro Rambaldi
Journal:  Haematologica       Date:  2010-12-20       Impact factor: 9.941

4.  Rare thromboses of cerebral, splanchnic and upper-extremity veins. A narrative review.

Authors:  Ida Martinelli; Valerio De Stefano
Journal:  Thromb Haemost       Date:  2010-03-29       Impact factor: 5.249

5.  Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms.

Authors:  Giuseppe Cella; Marina Marchetti; Fabrizio Vianello; Marina Panova-Noeva; Alfonso Vignoli; Laura Russo; Tiziano Barbui; Anna Falanga
Journal:  Thromb Haemost       Date:  2010-04-29       Impact factor: 5.249

Review 6.  The long pentraxin PTX3 in vascular pathology.

Authors:  Alberto Mantovani; Cecilia Garlanda; Barbara Bottazzi; Giuseppe Peri; Andrea Doni; Yeny Martinez de la Torre; Roberto Latini
Journal:  Vascul Pharmacol       Date:  2006-08-23       Impact factor: 5.773

Review 7.  The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.

Authors:  Giuseppe Danilo Norata; Cecilia Garlanda; Alberico Luigi Catapano
Journal:  Trends Cardiovasc Med       Date:  2010-02       Impact factor: 6.677

8.  C-reactive protein and risk of venous thromboembolism in the general population.

Authors:  Jeppe Zacho; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-13       Impact factor: 8.311

9.  Efficacy and safety of low-dose aspirin in polycythemia vera.

Authors:  Raffaele Landolfi; Roberto Marchioli; Jack Kutti; Heinz Gisslinger; Gianni Tognoni; Carlo Patrono; Tiziano Barbui
Journal:  N Engl J Med       Date:  2004-01-08       Impact factor: 91.245

10.  Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project.

Authors:  Stefan Blankenberg; Tanja Zeller; Olli Saarela; Aki S Havulinna; Frank Kee; Hugh Tunstall-Pedoe; Kari Kuulasmaa; John Yarnell; Renate B Schnabel; Philipp S Wild; Thomas F Münzel; Karl J Lackner; Laurence Tiret; Alun Evans; Veikko Salomaa
Journal:  Circulation       Date:  2010-05-24       Impact factor: 29.690
View more
  8 in total

Review 1.  Ruxolitinib: an oral Janus kinase 1 and Janus kinase 2 inhibitor in the management of myelofibrosis.

Authors:  Srdan Verstovsek
Journal:  Postgrad Med       Date:  2013-01       Impact factor: 3.840

2.  Carotid Artery Stiffness, Digital Endothelial Function, and Coronary Calcium in Patients with Essential Thrombocytosis, Free of Overt Atherosclerotic Disease.

Authors:  Matjaz Vrtovec; Ajda Anzic; Irena Preloznik Zupan; Katja Zaletel; Ales Blinc
Journal:  Radiol Oncol       Date:  2017-01-14       Impact factor: 2.991

3.  Predictive Value of Kozak Gene Polymorphism for Thrombosis in Patients with Philadelphia-Negative MPNs.

Authors:  Mohammed Sabry El-Ghonemy; Shaimaa El-Ashwah; May Denewer; Eman Adel Soliman; Mohammed El-Baiomy; Heidi Elkerdawy; Ahmed El-Sebaie
Journal:  Asian Pac J Cancer Prev       Date:  2021-04-01

Review 4.  Platelets Contribution to Thrombin Generation in Philadelphia-Negative Myeloproliferative Neoplasms: The "Circulating Wound" Model.

Authors:  Alessandro Lucchesi; Roberta Napolitano; Maria Teresa Bochicchio; Giulio Giordano; Mariasanta Napolitano
Journal:  Int J Mol Sci       Date:  2021-10-20       Impact factor: 5.923

Review 5.  Primary Immune Thrombocytopenia and Essential Thrombocythemia: So Different and yet Somehow Similar-Cases Series and a Review of the Literature.

Authors:  Marta Sobas; Maria Podolak-Dawidziak; Krzysztof Lewandowski; Michał Bator; Tomasz Wróbel
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

Review 6.  JAK2 Variant Signaling: Genetic, Hematologic and Immune Implication in Chronic Myeloproliferative Neoplasms.

Authors:  Dania G Torres; Jhemerson Paes; Allyson G da Costa; Adriana Malheiro; George V Silva; Lucivana P de Souza Mourão; Andréa M Tarragô
Journal:  Biomolecules       Date:  2022-02-11

7.  A Proliferation-Inducing Ligand and B-Cell Activating Factor Are Upregulated in Patients with Essential Thrombocythemia.

Authors:  Lukasz Bolkun; Marlena Tynecka; Tomasz Wasiluk; Jaroslaw Piszcz; Aleksandra Starosz; Kamil Grubczak; Marcin Moniuszko; Andrzej Eljaszewicz
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

Review 8.  MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives.

Authors:  Hans Carl Hasselbalch; Mads Emil Bjørn
Journal:  Mediators Inflamm       Date:  2015-10-28       Impact factor: 4.711
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.